Union Bancaire Privee, Ubp Sa Gilead Sciences, Inc. Transaction History
Union Bancaire Privee, Ubp Sa
- $4.34 Billion
- Q1 2025
A detailed history of Union Bancaire Privee, Ubp Sa transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Union Bancaire Privee, Ubp Sa holds 16,812 shares of GILD stock, worth $1.79 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
16,812
Previous 16,732
0.48%
Holding current value
$1.79 Million
Previous $1.55 Million
21.88%
% of portfolio
0.04%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,123Shares Held
989MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$12.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.3 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.64 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.43 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.17 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $133B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...